diabetes glp-1 agonist receptor agonists for individualized treatment of type 2 mellitus Evolution of GLP‐1 Receptor Agonists

Many patients begin with lower doses of GLP-1 drugs like Semaglutide or Tirzepatide to allow their bodies to adjust and to reduce the risk of gastrointestinal side effects, which are common with these medications

At MPR 0.5, the adjusted HR was quite similar to that in the main analysis (HR 0.87 [0.71-1.06]), but this became lower at MPR 0.75 (HR 0.75 [0.60 0.95]) and lower yet at MPR 0.95 (HR 0.62 [0.46 0.84]) When excluding subjects with follow-up times shorter than 6 months, 25,390 individuals remained, and the unadjusted HR for MOF was found to be 0.86 [0.731.02] for GLP-1 RAs compared to DPP-4is

Always speak with your doctor if you notice anything unusual

GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective

The first is as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes mellitus

2013;3(1):e001986